Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
NCT ID: NCT01295463
Last Updated: 2013-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
96 participants
OBSERVATIONAL
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Breast Cancer on Human Folliculogenesis
NCT07148141
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
NCT03141437
Evaluation of Attitudes About Fertility
NCT01705561
Evaluation of the Attitude of Pre Menopausal Women With Breast Cancer Faced With the Risk of Fertility Loss Caused by Chemotherapy
NCT02862990
Assessing Fertility Potential in Female Cancer Survivors
NCT01143844
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center.
Secondary
* To analyze whether the information received by patients is related to the desire to be parents.
* To analyze whether the information received by patients is related to the desire to be informed.
* To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients.
OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire administration
study of socioeconomic and demographic variables
assessment of therapy complications
fertility assessment and management
psychosocial assessment and care
quality-of-life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma
* Free of disease
* Completed treatment within the past 1-2 years
PATIENT CHARACTERISTICS:
* ECOG performance status 0-1
* Must be able to read and self-complete study questionnaires
* No psychological conditions that may prevent participation in the study
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No concurrent treatment (hormonal treatment for breast cancer is allowed)
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Català d'Oncologia
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Josefina Rivera, RGN, MSN
Role: PRINCIPAL_INVESTIGATOR
Institut Català d'Oncologia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Catala D'Oncologia
L'Hospitalet de Llobregat, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000695000
Identifier Type: REGISTRY
Identifier Source: secondary_id
EU-21105
Identifier Type: -
Identifier Source: secondary_id
ICO-FERTI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.